Patient Perceptions of Generic Medicines: A Mixed-Methods Study
- 243 Downloads
In an attempt to benefit from the cost-savings associated with use of generic medicines, in June 2013 Ireland introduced generic substitution and reference pricing for the first time. However, perceptions of Irish patients towards generic medicines have not been published previously. Therefore, the objective of this study was to assess how generic medicines were perceived amongst patients in the time leading up to the enactment of the new legislation.
A total of 42 patients were recruited from general practices affiliated with the Graduate Entry Medical School at the University of Limerick and from community pharmacies. Interviews were semi-structured and included quantitative assessments of opinions using 15 structured questions and a five-point Likert scale response system. Interview transcripts were coded and thematically analysed using NVivo (version 9), for qualitative data. Quantitative data were analysed using SPSS (version 20).
Nearly one-third (31 %) of patients had no knowledge of generic medicines and 39 % of those exhibited confusion between the words ‘generic’ and ‘genetic’. Almost one-quarter (24 %) held the view that generics were of poorer quality than originators, while 18 % expressed the opinion that generics do not work as well as originator products. Approximately one-third (30 %) of patients believed that generics were manufactured to a poorer quality, with 29 % holding the view that generics are less expensive due to being of inferior quality. Nearly 90 % of patients stated they would take a generic medicine if it were prescribed by their GP; however, 24 % of patients stated a preference, if offered a choice, for the originator medication. Additionally, a majority of patients (86 %) were in favour of reference pricing and generic substitution. Of the patients interviewed, 50 % stated that a leaflet, or similar, with appropriate, understandable, and accessible information regarding generic medicines would be of use to them.
This is the first study of patients’ attitudes towards generic medicines in Ireland. Conducted in the time period leading up to the implementation of legislation promoting the use of generic medicines, it highlights variable knowledge about generic medicines among this key stakeholder group. Although patients are supportive of their more widespread use, concerns regarding safety, clinical effectiveness, and manufacturing quality of generic medicines were identified.
KeywordsCommunity Pharmacy Generic Medicine Reference Price Generic Substitution Originator Product
This work was supported in part by a scholarship from the Faculty of Education and Health Sciences, University of Limerick, Ireland.
The authors wish to express their sincere thanks to all of the patients who took part in the interviews and also to the individual GPs and pharmacists who permitted patients to be recruited from their practices or pharmacies.
The authors each declare that they do not have any conflicts of interest.
SD designed the study and carried out the interviews and data analysis. SD was the primary author of the manuscript.
BS approved the design of the study and provided critical review of the manuscript.
CD approved the design of the study and provided critical review of the manuscript and is the overall guarantor.
WC approved the design of the study and provided critical review of the manuscript.
- 1.Health (Pricing and Supply of Medical Goods) Act 2013. http://www.irishstatutebook.ie/2013/en/act/pub/0014/index.html.
- 2.Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol. 2013;14(1):1.PubMedCentralPubMedCrossRefGoogle Scholar
- 4.Timonen J, Bengtstrom M, Karttunen P, Ahonen R. The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies’ perspective one year and five years after the introduction of generic substitution in Finland. BMC Clin Pharmacol. 2010;10:15.PubMedCentralPubMedCrossRefGoogle Scholar
- 6.Ireland: Pharmaceutical Prices, Prescribing Practices and Usage of Generics in a Comparative Context. http://www.esri.ie/UserFiles/publications/RS32_Pharma.pdf.
- 10.Gonzalez Hernando S, Gonzalez Mieres C, Diaz Martin AM. Intention of purchasing generic prescription drugs on the part of consumers in Asturias. Spain. Rev Esp Salud Publica. 2003;77(6):691–9.Google Scholar
- 25.Murphy MB: Review of indicative drug target savings scheme. In: Review of indicative drug target savings scheme. Lenus website: Health Service Executive; 1997.Google Scholar
- 26.Delivery of Pharmaceuticals in Ireland—Getting a Bigger Bang for the Buck. http://www.esri.ie/UserFiles/publications/RS24.pdf.
- 28.Proposed Model for Reference Pricing and Generic Substitution. http://www.dohc.ie/publications/pdf/reference_pricing_generic_substitution.pdf?direct=1. Archived at: http://www.webcitation.org/6FD1WRh1e.
- 29.Likert R: A technique for the measurement of attitudes. Arch Psychol. 1932;140:5–55.Google Scholar
- 36.Dunne S, Cummins N, Hannigan A, Shannon B, Dunne C, Cullen W. A method for the design and development of medical or health care information websites to optimize search engine results page rankings on Google. J Med Internet Res. 2013;15(8):e183.Google Scholar
- 42.Schönfelder W. CAQDAS and qualitative syllogism logic—NVivo 8 and MAXQDA 10 compared. Forum: Qualitative Soc. Res. 2011;12(1): Article 21.Google Scholar